Library
PubMed
research article
Professional

Clinical and Microbiological Effects ofK12 Lozenges and Zinc Mouthrinse on Persistent Intra-Oral Halitosis.

Source: PubMed, NCBI / U.S. National Library of Medicine

MicroorganismsBolos Adrian, Bolos Otilia Cornelia, Maghet Edida, et al.Published 4/28/2026Last synced 5/30/2026Status: syncedPMID: 42197375DOI: 10.3390/microorganisms14050990

Halitosis is a common condition with substantial psychosocial impact, frequently driven by intra-oral biofilm, tongue coating, and reduced salivary clearance. This study compared the short-term effectiveness of standardized counseling alone, probiotic lozenges containingK12, and a zinc-containing mouthrinse in adults with persistent intra-oral halitosis. In this 4-week, parallel-group, randomized pragmatic trial, 117 adults with bothersome halitosis for at least 3 months and baseline organoleptic score &#x2265; 2 were allocated 1:1:1 to standard care, probiotic lozenges, or zinc mouthrinse. All participants received standardized counseling and tongue cleaning instructions. The primary endpoint was change in volatile sulfur compounds (VSCs) measured by portable sulfide monitoring. Secondary outcomes included organoleptic score, Halitosis Associated Life-Quality Test (HALT), Oral Health Impact Profile-14 (OHIP-14), tongue coating, plaque, and salivaryquantified by qPCR. Baseline demographic, clinical, and biochemical characteristics were comparable across groups. All interventions improved outcomes over 4 weeks, but improvements followed a consistent gradient favoring zinc mouthrinse, followed by probiotic lozenges, then standard care. Mean VSC reduction was -12.7 &#xb1; 33.9 ppb with standard care, -47.3 &#xb1; 42.2 ppb with probiotics, and -78.5 &#xb1; 36.3 ppb with zinc mouthrinse (< 0.001). Organoleptic scores improved by -0.2 &#xb1; 0.7, -0.8 &#xb1; 0.8, and -1.2 &#xb1; 0.

Abstract

Halitosis is a common condition with substantial psychosocial impact, frequently driven by intra-oral biofilm, tongue coating, and reduced salivary clearance. This study compared the short-term effectiveness of standardized counseling alone, probiotic lozenges containingK12, and a zinc-containing mouthrinse in adults with persistent intra-oral halitosis. In this 4-week, parallel-group, randomized pragmatic trial, 117 adults with bothersome halitosis for at least 3 months and baseline organoleptic score &#x2265; 2 were allocated 1:1:1 to standard care, probiotic lozenges, or zinc mouthrinse. All participants received standardized counseling and tongue cleaning instructions. The primary endpoint was change in volatile sulfur compounds (VSCs) measured by portable sulfide monitoring. Secondary outcomes included organoleptic score, Halitosis Associated Life-Quality Test (HALT), Oral Health Impact Profile-14 (OHIP-14), tongue coating, plaque, and salivaryquantified by qPCR. Baseline demographic, clinical, and biochemical characteristics were comparable across groups. All interventions improved outcomes over 4 weeks, but improvements followed a consistent gradient favoring zinc mouthrinse, followed by probiotic lozenges, then standard care. Mean VSC reduction was -12.7 &#xb1; 33.9 ppb with standard care, -47.3 &#xb1; 42.2 ppb with probiotics, and -78.5 &#xb1; 36.3 ppb with zinc mouthrinse (< 0.001). Organoleptic scores improved by -0.2 &#xb1; 0.7, -0.8 &#xb1; 0.8, and -1.2 &#xb1; 0.8, respectively (< 0.001). HALT and OHIP-14 scores showed parallel reductions, and moderate/severe halitosis at week 4 remained most frequent in the standard care group (58.9%) and least frequent in the zinc group (20.5%;= 0.004). Both active adjunctive strategies improved intra-oral halitosis beyond standardized counseling alone, but the zinc-containing mouthrinse produced the greatest short-term benefits across objective, clinician-rated, and patient-reported outcomes. These findings support zinc-based rinses as a practical short-term adjunct for managing persistent intra-oral halitosis in outpatient dental care. Durability after discontinuation and potential relapse beyond 4 weeks were not assessed in this trial.

Educational only
This information is for general education and is not medical advice. Always talk to a licensed U.S. clinician about your situation, medications, or treatment decisions.